An Open-label, Single Arm, Sequential, Single Centre Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Semaglutide (Primary) ; Digoxin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 18 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2015 Planned End Date changed from 1 Apr 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.